Highlights Rhythm Biosciences Limited

Equities

RHY

AU000000RHY2

Delayed Australian S.E. Other stock markets 09:32:54 2024-05-09 pm EDT			5-day change	1st Jan Change
0.079 ^AUD	-1.25%		-3.66%	-41.48%

Apr. 24	Rhythm Biosciences Appoints CEO; Shares Down 3%	MT
Mar. 21	Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3%	Mar. 20	MT
Rhythm Biosciences Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28	CI
Rhythm Biosciences Receives First Tranche of R&D Tax Rebate	Nov. 14	MT
Rhythm Biosciences Joins Forces to Automate Cancer Test Kit	23-09-13	MT
Rhythm Biosciences Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
Rhythm Biosciences Signs Deal for UK Entry of Cancer Test	23-05-24	MT
Rhythm Biosciences Secures UK Certification for Diagnostic Test; Shares Surge 89%	23-05-17	MT
Rhythm Biosciences Pulls Out TGA Submission for Colorectal Cancer Diagnostic Kit	23-03-06	MT
Rhythm Biosciences Limited Provides Update to TGA Submission for ColoSTAT® Test-Kit	23-03-05	CI
Rhythm Biosciences Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-22	CI
Rhythm Biosciences Expands Executive Management Team, Registers Diagnostic Blood Test With New Zealand	22-11-02	MT
Rhythm Biosciences Secures $2 Million Tax Rebate; Shares Rise 3%	22-10-20	MT
Rhythm Biosciences Chair Sells Shares to Domestic Fund Manager	22-09-09	MT
Rhythm Biosciences Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-29	CI
Rhythm Biosciences Limited Advances Platform Expansion with Other Cancers	22-07-18	CI
Rhythm Biosciences Files Listing for Colorectal Cancer Diagnostic Test	22-05-12	MT
Rhythm Biosciences Limited Closes Final Clinical Trial Site	22-05-03	CI
Rhythm Biosciences Meets Primary Endpoint in Accuracy Trial for Cancer Diagnostic Kit; Shares Rally 17%	22-04-04	MT
Rhythm Biosciences Announces the Statistical Analysis Outcomes of Its Clinical Trial (Study 7) as Verified by Rhythm's Third-Party Statisticians for ColoSTAT ®	22-04-03	CI
Rhythm Biosciences Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Rhythm Biosciences Limited

Equities

RHY

AU000000RHY2

Highlights

Filters